BioAtla Inc.

NASDAQ: BCAB
Share price (1/14/26): $0.34
Market cap (1/14/26): $19.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Waldron Richard A

Short Jay M Phd

Vasquez Christian

OPOKA INVESTMENT FUND Co

News Filter

Unregistered Sales of Equity Securities, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Other Events, Financial Statements or Exhibits

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) Into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma

Shareholder Vote Results, Other Events

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission